About
ReaGenics develops and scales plant cell bioreactor technology to produce pharmaceutical-grade, botanically-derived molecules without the need for large-scale industrial plant cultivation.
Explore REAGENICS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.